APO-FLUNISOLIDE NASAL SPRAY DIN 02239288
Health Canada record
| Active ingredient(s) | FLUNISOLIDE 0.25 MG |
|---|---|
| Dosage form | Metered-Dose Pump |
| Route | Nasal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | R01AD04 FLUNISOLIDE |
| Original market date | 10-Mar-2000 |
| Current status date | 20-Feb-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUNISOLIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00790486 | BRONALIDE INHAL 250MCG/AEM | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Metered-Dose Aerosol | FLUNISOLIDE 250 MCG | Cancelled Post Market |
| 02230306 | NOVO-FLUNISOLIDE | NOVOPHARM LIMITED | Spray | FLUNISOLIDE 25 MCG | Cancelled Post Market |
| 01927167 | PMS-FLUNISOLIDE | PHARMASCIENCE INC | Spray | FLUNISOLIDE 0.025 % | Cancelled Post Market |
| 00878790 | RATIO-FLUNISOLIDE | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Spray | FLUNISOLIDE 25 MCG | Cancelled Post Market |
| 02162687 | RHINALAR NASAL MIST | IVAX LABORATORIES INCORPORATED | Spray; Solution | FLUNISOLIDE 25 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14000 | 2013-01-08 | New Drug Submission (NDS) | manufacturer name change |
| 1775 | 1999-12-09 | New Drug Submission (NDS) | |
| 1788 | 1999-10-21 | New Drug Submission (NDS) |
International API supply for FLUNISOLIDE
5 active FDA Drug Master Files.
Request a quote for APO-FLUNISOLIDE NASAL SPRAY